Inventor
KUHNKE JOACHIM
DE32 patents
⚠️ This page may combine multiple inventors who share the name “KUHNKE JOACHIM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING AG
11 patentsUS7115645B2Oct 3, 2006
1,2 diarylbenzimidazoles and their pharmaceutical use
SCHERING AG22 citations92
US6855714B2Feb 15, 2005
1-alkyl-2-aryl-benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
SCHERING AG29 citations91
US7504410B2Mar 17, 2009
Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
SCHERING AG13 citations81
US5827842AOct 27, 1998
14α, 17α-C2 -bridged norprogesterone derivatives
SCHERING AG6 citations73
US6962932B2Nov 8, 2005
1-phenyl-2-heteroaryl-substituted benzimdazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
SCHERING AG6 citations72
US7345075B2Mar 18, 2008
1,2 diarylbenzimidazoles and their pharmaceutical use
SCHERING AG5 citations62
US7329679B2Feb 12, 2008
1,2 Diarylbenzimidazoles and their pharmaceutical use
SCHERING AG3 citations62
US6147065ANov 14, 2000
14-α, 17-α-C2 bridged norprogesterone derivatives
SCHERING AG0 citations51
US7196202B2Mar 27, 2007
1-aryl-2-N-, S- or O-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
SCHERING AG0 citations48
US6903126B2Jun 7, 2005
1-Aryl-2-N-, S- or O-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
SCHERING AG0 citations48
US6683197B1Jan 27, 2004
Process for the production of 4,4-dimethyl-5α-cholesta-8,14,24-trien-3β-01 and intermediate products in process (I)
SCHERING AG0 citations40
BAYER AG
6 patentsUS10981932B2Apr 20, 2021
Macrocyclic indole derivatives
BAYER AG9 citations83
US11492358B1Nov 8, 2022
Macrocyclic indole derivatives
BAYER AG3 citations71
US11478451B1Oct 25, 2022
Macrocyclic chlorine substituted indole derivatives
BAYER AG3 citations71
US11447504B2Sep 20, 2022
Macrocyclic chlorine substituted indole derivatives
BAYER AG3 citations71
US11440923B2Sep 13, 2022
Substituted macrocyclic indole derivatives
BAYER AG3 citations71
US11891404B2Feb 6, 2024
Substituted macrocyclic indole derivatives
BAYER AG1 citations61
Bayer Pharma AG
4 patentsUS9708311B2Jul 18, 2017
Benzimidazole derivatives as EP4 antagonists
Bayer Pharma AG2 citations71
US10350206B2Jul 16, 2019
Benzyl substituted indazoles as BUB1 inhibitors
Bayer Pharma AG1 citations61
US9890147B2Feb 13, 2018
2,3-benzodiazepines
Bayer Pharma AG2 citations59
US9663523B2May 30, 2017
BET protein-inhibiting 5-aryltriazoleazepines
Bayer Pharma AG0 citations37
BROAD INST INC
3 patentsKLAR ULRICH
3 patentsUS8623850B2Jan 7, 2014
15, 16-methylene-17-(1′-propenyl)-17,3′-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative
KLAR ULRICH1 citations50
US8937058B2Jan 20, 2015
17-hydroxy-19-nor-21-carboxylic acid-steroid γ-lactone derivative, use thereof, and medicament containing the derivative
KLAR ULRICH0 citations49
US9034856B2May 19, 2015
17-(1′propenyl)-17-3′-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative
KLAR ULRICH0 citations39
BAYER SCHERING PHARMA AG
2 patentsUS7846917B2Dec 7, 2010
18-Methyl-19-norandrost-4-ene 17, 17-spiro ether (18-methyl-19-nor-20-spirox-4-en-3-one), and pharmaceutical products comprising the same
BAYER SCHERING PHARMA AG4 citations59
US7683081B2Mar 23, 2010
1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
BAYER SCHERING PHARMA AG0 citations51